EUVIMEDEUVIMED entdecken
Crossref

Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury

Zhiwu Wu, Ying Xu, Ximing Guo, Zhilan Zhang, Jinxin Wang iD, Yiqun Tang

Planta Medica · 01.07.2025 · 91 (08) · 451-460

DOI: 10.1055/a-2565-8285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.07.2025. Verfasst von Zhiwu Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P. R. China. Hauptthemen laut MEDLINE: Abietanes, Cardiotonic Agents, Myocardial Ischemia, Myocardial Infarction. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Double-First-Class University Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tanshinone ⅡA (TSA), a component of traditional Chinese medicine, effectively protects against myocardial injury. However, its clinical application is limited by poor water solubility and a short half-life. In this study, we report on four TSA derivatives designed and synthesized by our research group. The protective activity against hypoxia-reoxygenation injury in cells was evaluated, and derivative Ⅰ-3 was selected for in vivo experiments to verify its myocardial protective activity in rats with myocardial infarction. The results demonstrated that these four compounds could protect neonatal rat cardiomyocytes from hypoxia-reoxygenation injury. Among the derivatives, Ⅰ-3 showing superior protective effects, we found that Ⅰ-3 has enhanced metabolic stability and an extended half-life. Ⅰ-3 exhibited superior biological activity, effectively reducing the heart infarction area, alleviating myocardial hypertrophy, and enhancing cardiac pumping function. Ⅰ-3 reported in the present work represents a novel and effective derivative of TSA, showing great potential for the treatment of myocardial ischemia (MI).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesCardiotonic AgentsMyocardial IschemiaMyocardial InfarctionMyocardial Reperfusion InjuryAnimalsMyocytes, CardiacRatsRats, Sprague-DawleyMale

Substanzen

AbietanestanshinoneCardiotonic Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

ORCID-Profile: Jinxin Wang

Förderung

  • National Natural Science Foundation of China
  • Double-First-Class University Project

Zitieren

APA

Wu, Z., Xu, Y., Guo, X., Zhang, Z., Wang, J., & Tang, Y. (2025). Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury. Planta Medica, 91(08), 451-460. https://doi.org/10.1055/a-2565-8285

Vancouver

Wu Z, Xu Y, Guo X, Zhang Z, Wang J, Tang Y. Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury. Planta Medica. 2025;91(08):451-460. doi:10.1055/a-2565-8285

BibTeX
@article{Wu2025,
  author = {Wu, Zhiwu and Xu, Ying and Guo, Ximing and Zhang, Zhilan and Wang, Jinxin and Tang, Yiqun},
  title = {Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury},
  journal = {Planta Medica},
  year = {2025},
  volume = {91},
  number = {08},
  pages = {451--460},
  doi = {10.1055/a-2565-8285}
}
Kostenlos starten →